We provide you with 20 years of free, institutional-grade data for SANA stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of SANA. Explore the full financial landscape of SANA stock.
Total insider purchase within 3 month on this page: $0
Total insider selling within 3 month on this page: -$0
| Name | Action | Shares | Avg Price | Amount | Reported Date |
|---|---|---|---|---|---|
| Bishop Hans Edgar | Grant, award...etc | 7,842 | 2025-07-08 | ||
| Bishop Hans Edgar | Grant, award...etc | 16,339 | 2025-04-08 | ||
| Wyrick Susan D. | Sale | -836 | $2.56 | $2,140 | 2025-03-10 |
| Wyrick Susan D. | Derivatives Exercise | 3,250 | 2025-03-10 | ||
| Cassidy Bernard J | Sale | -2,833 | $2.56 | $7,252 | 2025-03-10 |
| Cassidy Bernard J | Derivatives Exercise | 11,041 | 2025-03-10 | ||
| Harr Steve | Sale | -12,820 | $2.56 | $32,819 | 2025-03-10 |
| Harr Steve | Derivatives Exercise | 50,000 | 2025-03-10 | ||
| Wyrick Susan D. | Sale | -490 | $2.56 | $1,254 | 2025-03-03 |
| Wyrick Susan D. | Derivatives Exercise | 1,525 | 2025-03-03 | ||
| FMR LLC | Sale | -290,912 | $6.11 | $1,777,472 | 2025-01-10 |
| Bishop Hans Edgar | Grant, award...etc | 14,285 | 2025-01-07 | ||
| Wyrick Susan D. | Sale | -1,566 | $1.65 | $2,584 | 2025-01-03 |
| Wyrick Susan D. | Derivatives Exercise | 5,000 | 2025-01-03 | ||
| Wyrick Susan D. | Initial | 2024-10-15 | |||
| Bishop Hans Edgar | Grant, award...etc | 5,938 | 2024-10-09 | ||
| Mulligan Richard | Sale | -300,000 | $4.08 | $1,225,140 | 2024-09-26 |
| Bishop Hans Edgar | Grant, award...etc | 4,911 | 2024-07-08 | ||
| Bishop Hans Edgar | Grant, award...etc | 2,774 | 2024-04-08 | ||
| Yang Patrick Y | Sale | -25,000 | $9.45 | $236,300 | 2024-03-11 |
| Flagship Pioneering Inc. | Open Market Purchase | 2,727,272 | $5.5 | 2024-02-14 | |
| ARCH Venture Fund X, L.P. | Open Market Purchase | 727,272 | $5.5 | 2024-02-12 | |
| ARCH Venture Fund X, L.P. | Open Market Purchase | 727,272 | $5.5 | 2024-02-12 | |
| ARCH Venture Fund X, L.P. | Open Market Purchase | 363,637 | $5.5 | 2024-02-12 | |
| CRANDELL KEITH | Open Market Purchase | 727,272 | $5.5 | 2024-02-12 | |
| CRANDELL KEITH | Open Market Purchase | 727,272 | $5.5 | 2024-02-12 | |
| CRANDELL KEITH | Open Market Purchase | 363,637 | $5.5 | 2024-02-12 | |
| NELSEN ROBERT | Open Market Purchase | 727,272 | $5.5 | 2024-02-12 | |
| NELSEN ROBERT | Open Market Purchase | 727,272 | $5.5 | 2024-02-12 | |
| NELSEN ROBERT | Open Market Purchase | 363,637 | $5.5 | 2024-02-12 | |
| Bishop Hans Edgar | Grant, award...etc | 4,901 | 2024-01-08 | ||
| Wilderotter Mary Agnes | Grant, award...etc | 1,470 | 2024-01-08 | ||
| Hordo Christian | Sale | -75,000 | $4 | $300,098 | 2023-12-18 |
| Wilderotter Mary Agnes | Grant, award...etc | 2,077 | 2023-10-06 | ||
| Bishop Hans Edgar | Grant, award...etc | 6,925 | 2023-10-06 | ||
| Bishop Hans Edgar | Grant, award...etc | 4,152 | 2023-07-06 | ||
| Wilderotter Mary Agnes | Grant, award...etc | 1,245 | 2023-07-06 | ||
| Flagship Ventures Fund V General Partner LLC | Sale | -45,057 | $6.31 | $284,134 | 2023-06-08 |
| Flagship Ventures Fund V General Partner LLC | Sale | -358,701 | $6.31 | $2,262,004 | 2023-06-08 |
| Flagship Ventures Fund V General Partner LLC | Sale | -62,037 | $6.57 | $407,285 | 2023-05-26 |
| Flagship Ventures Fund V General Partner LLC | Sale | -483,205 | $6.57 | $3,172,337 | 2023-05-26 |
| Bishop Hans Edgar | Grant, award...etc | 7,716 | 2023-04-06 | ||
| Wilderotter Mary Agnes | Grant, award...etc | 2,314 | 2023-04-06 | ||
| Bilenker Joshua H. | Open Market Purchase | 20,000 | $25 | 2023-02-17 | |
| NELSEN ROBERT | Grant, award...etc | 536 | 2023-01-06 | ||
| Bishop Hans Edgar | Grant, award...etc | 6,702 | 2023-01-06 | ||
| NELSEN ROBERT | Grant, award...etc | 321 | 2022-10-06 | ||
| Bishop Hans Edgar | Grant, award...etc | 4,012 | 2022-10-06 |
The information provided in this report about SANA stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Sana Biotechnology, Inc(NASDAQ:SANA) 
Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines. The company develops in vivo and ex vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including oncology, diabetes, central nervous system disorders, cardiov...
Share this website to your friends